2[2]Lenore Kakita.J Am Acad Dermatol,2000,43(2):51
3[3]Lyn Grenther. J Am Acad Dermatol,2000,43(2)36
4[4]Mark Lebwohl.J Am Acad Dermatol,2000,43(2):43
同被引文献15
1Linden KG, Weinstein GD. Psoriasis: Current perspectives with an emphasis on treatment [ J]. Arch Dermatol, 1998, 134( 1 ) :57 -60.
2Lebwohl MG, Breneman DL, Goffe BS, et al. Tazaroten 0.1% gel plus conticosteroid in the treatment of plaque psoriasis [ J ]. Am Acad Dermatol, 1998,39:590 - 596.
3Matsumoto K, Hashimoto K, Kiyoki M, et al. Effect of 1, 24R - dihydroxyvitamin D3 on the growth of human keratinocytes [ J ]. J Dermatol, 1990,17 (2) : 97 - 103.
4Glade CP, van Erp PE, van Hooijdonk CA, et al. Topical treatment of psoriatic plaques with 1 alpha, 24 dihydroxyvitamin D3:a muhiparameter flow cytometrcial analysis of epidermal growth, differentiation and inflammation [ J ]. Acta Derm Venereol, 1995,75 (5) :381 - 385.
5Menter A.Pharmacokinetics and safety of tazarotene[J].J Am Ac ad Dermatol,2000,31-35.
6Hardman JG,Limbird LE,Gilman AG,et al.Goodman & gilman′s the pharm acological basis of therapeutics[M].10th.ed.McGraw-Hill Companies,2001,1 802.
7Chandraratna RAS.Tazarotene:the first receptor-selective topical reti noid for the treatment of psoriasis[J].J Am Acad Dermatol,1997,37:14.
8Duvic M,Asano AT,Kerenyi M,et al.Tazarotene induces epidermal cell differentiation in the mouse tail test used as an animal model for psoriasis.Skin Pharmacol Appl Skin Physiol 2000;13(5):285-291.
9Lavker RM,Leyde JJ,Thome EG.An ultrastructural study of the effects of topical tretinoin on microcomedones.Clin Ther 1992;14(6):773-780.
10Challker DK,Lesher JL Jr,Smith JG,et al.Efficacy of topical is otretinoin 0.05% gel in acne vulgaris:results of a multicenter,double-blind investigation.Am Acad Dermatol 1987;7:251-254.
